Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cytomx Therapeutics INC. (CTMX)

177 + Investors. Track Smart Money conviction in CTMX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
59%

Smart Money Signals — CTMX

Based on 179 hedge funds · latest filing: 2026 Q2 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
179 hedge funds hold CTMX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +118% more funds vs a year ago

fund count last 6Q
+97 new funds entered over the past year (+118% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

122 buying84 selling
Last quarter: 122 funds bought or added vs 84 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-28 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 34 → 40 → 78 → 50. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

45% of holders stayed for 2+ years

■ 45% conviction (2yr+) ■ 19% medium ■ 36% new
80 out of 179 hedge funds have held CTMX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

31 → 34 → 40 → 78 → 50 new funds/Q
New funds entering each quarter: 34 → 40 → 78 → 50. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 54% veterans vs 40% newcomers

■ 54% veterans ■ 5% 1-2yr ■ 40% new
Entry-cohort mix of 186 holders: 101 (54%) are 2+ year veterans, 10 entered 1–2 years ago, and 75 (40%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
43 of 178 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in CTMX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
5.4
out of 10
Moderate Exit Risk
Exit risk score 5.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CTMX

In 2026 Q2, 122 hedge funds were net buyers of CTMX (50 opened a new position, 72 added to an existing one), while 84 reduced or exited (34 trimmed, 50 sold completely) — a 59% buyer ratio, indicating a slight buying edge. 42% of total institutional value in CTMX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 179.

Hedge Fund Ownership: CTMX

How many hedge funds hold CTMX — quarterly history vs. share price
Quarterly hedge fund ownership of CTMX vs. share price

Market Analysis: CTMX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CTMX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cytomx Therapeutics INC. (CTMX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CTMX has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 48d ago
CTMX
-29.0%
XLV
+9.8%

CTMX outperformed XLV by -38.8% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 3d ago
CTMX
-5.4%
XLV
-2.1%

Since the filing became public, CTMX outperformed XLV by -3.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 2 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: CTMX
2026 Q3 Stats Unlock in 2 days 177 + Investors

Track Smart Money conviction in CTMX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 177 179 -1.12%
13F Shares 214M 198M 7.99%
Total Value $803M $932M -13.82%
New Positions 50 78 -28
Increased Positions 66 59 +7
Closed Positions 51 21 +30
Reduced Positions 35 26 +9
Total Calls 5 8 -37.5%
Total Puts 3 4 -25.0%
PUT/CALL Ratio 0.6 0.5 Bullish

Statistics: CTMX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

177 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CTMX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 CTMX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Peak Financial Advisors LLC 0.54% 462,061 $1.3M
2 Schulhoff & Co Inc 0.53% 477,550 $1.3M
3 Perceptive Advisors LLC 0.44% 9,268,061 $25.2M
4 Stonepine Capital Management, LLC 0.38% 220,000 $598K
5 Siren, L.L.C. 0.22% 3,457,711 $9.4M
6 Miller Financial Services LLC 0.18% 87,000 $237K
7 Aspire Growth Partners LLC 0.15% 102,254 $278K
8 Forefront Analytics, LLC 0.11% 40,148 $109K
9 PSP Research LLC 0.07% 39,400 $107K
10 Baker BROS. Advisors LP 0.06% 4,975,826 $13.5M
11 Virtus Investment Advisers, LLC 0.06% 105,427 $287K
12 Palumbo Wealth Management LLC 0.05% 79,879 $217K
13 Silverback Asset Management LLC 0.04% 100,000 $525K
14 Dynamic Technology Lab Private Ltd 0.03% 47,656 $130K
15 Tema Etfs LLC 0.02% 246,277 $670K
16 Pursue Wealth Partners LLC 0.02% 14,492 $39K
17 NLB Skladi, upravljanje premozenja, d.o.o. 0.02% 200,000 $544K
18 Congress Park Capital LLC 0.02% 27,171 $74K
19 Landscape Capital Management, L.L.C. 0.02% 94,240 $256K
20 IFG Advisory, LLC 0.02% 209,243 $569K
21 Gilder Gagnon Howe & Co LLC 0.02% 651,414 $1.8M
22 Nierenberg Investment Management Company, LLC 0.02% 12,555 $34K
23 Robertson Stephens Wealth Management, LLC 0.01% 220,000 $598K
24 Jump Financial, LLC 0.01% 737,868 $2.0M
25 Pale Fire Capital SE 0.01% 61,000 $166K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cytomx Therapeutics INC. (CTMX)

What does the Smart Money Trend signal show for CTMX?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for CTMX?

Slight buying edge — 59% buying: Last quarter: 122 funds bought or added vs 84 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CTMX holders?

Elite ownership — 42% AUM from top-100 funds: 43 of 178 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in CTMX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CTMX?

45% of holders stayed for 2+ years: 80 out of 179 hedge funds have held CTMX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cytomx Therapeutics INC. (CTMX) following the 2026 Q3 hedge fund 13F filings?

As of today, CTMX has moved -5.4% since the 2026 Q3 13F filing date (November 14, 2026), compared to -2.1% for the XLV sector ETF — an outperformance of -3.3%. Since the quarter end (September 30, 2026), CTMX has gained -29.0% vs +9.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →